AstraZeneca Divests Rights to Two Cardiovascular Drugs for $400 Million

cafead

Administrator
Staff member
  • cafead   Nov 01, 2020 at 02:12: PM
via AstraZeneca is divesting two cardiovascular drugs to Germany’s Cheplapharm Arzneimittel GmbH for $400 million, which will allow the UK pharma giant to reinvest in its main therapy areas.

article source